• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

The day in deals

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
January 2, 2014, 2:52 PM ET

To get deals in your inbox each morning, sign up for our Term Sheet newsletter

Nest Labs, a Palo Alto, Calif.-based maker of smart home devices like thermostats and smoke detectors, is raising upwards of $150 million in a new VC round that would value the company  north of $2 billion, according to Re/code. DST is expected to lead the round, with return backers including Google Ventures, Kleiner Perkins, Generation Investment Management, Lightspeed Venture Partners, Shasta Ventures and Venrock. www.nest.com

Didi Dache, a Chinese taxi-booking app, has raised $100 million in Series C funding from CITIC Capital ($60m) and existing investors like Tencent ($30m), according to a Chinese media report.www.xiaojukeji.com

Alexar Therapeutics Inc., a developer of liver x receptor agonists for both systemic and local use, has raised $21.5 million in Series A funding. The company was formed by NeXeption LLC, while the investment was co-led by New Science Ventures and Third Point Ventures. Palo Alto Investors also participated. www.alexartx.com

Agilis Biotherapeutics LLC, a New York-based synthetic biology-based company focused on rare genetic diseases, has raised $8 million in new VC funding. The company also announced a partnership with Intrexon Corp. (NYSE: XON), in order to develop a treatment for Friedreich’s ataxia.www.agilisbio.com

Floored, a New York-based provider of 3D data capture and visualization solutions for the real estate, architecture, interior design and furniture industries, has raised $5.26 million in Series A funding. RRE Ventures led the round, and was joined by Greycroft Partners and return backers Two Sigma Ventures, Lerer Ventures, and Felicis Ventures. www.floored.com

Retrofit, a Chicago-based provider of weight loss programs, has raised $5 million in Series B funding.Cambia Health Solutions led the round, and was joined by return backer DFJ. The company previously raised more than $8 million. www.retrofitme.com

Breaker, a producer and distributor of mobile video entertainment, has raised $2 million in seed funding. Japan’s Dream Incubator Inc. led the round, and was joined by Siemer Ventures. www.brkr.jp

AirVend, a Provo, Utah-based maker of cashless touchscreen devices for vending machines that will aid in nutrition disclosure regulations, has raised $1.2 million in seed funding. 365 Retail Markets led the round, and was joined by PS27 Ventures. www.air-vend.com

PRIVATE EQUITY DEALS

KIK Custom Products Inc., a portfolio company of CIC Capital Partners, has acquired the consumer business of Chemtura Corp. (NYSE: CHMT) for $300 million. www.kikcorp.com

New England Orthotic & Prosthetic Systems, a Branford, Conn.–based provider of orthotic and prosthetic patient care products and services, has raised an undisclosed amount of mezzanine funding from F.N.B. Capital Partners. New England Orthotic & Prosthetic Systems is a portfolio company ofSummer Street Capital Partners. www.neops.com

Peak Rock Capital has acquired Natural American Foods Inc., an Onsted, Mich.–based producer and distributor of honey and other food products. No financial terms were disclosed.www.naturalamericanfoods.com

Yumi’s Quality Foods, an Australian snack-maker, has raised an undisclosed amount of equity funding from Anacacia Capital. www.yumis.com.au

IPOs

Dicerna Pharmaceuticals, a Watertown, MA-based pharmaceutical company that develops RNA interference-based therapeutics, has filed for a $69 million IPO. It plans to trade on the Nasdaq under ticker symbol DRNA, with Jefferies, Leerink Swann and Stifel serving as lead underwriters. The company reports around a $10 million net loss on $7 million in revenue for 2013. Shareholders include Domain Associates (16.8% pre-IPO stake), Skyline Ventures (14.7%), Deerfield Management (13.4%), RA Capital (13.4%), Abingworth Management (10.3%), Brookside Capital (9.4%), S.R. One Ltd. (8%) and Oxford Bioscience Partners (7.3%). www.dicerna.com

Revance Therapeutics Inc., a Newark, Calif.-based developer of a platform technology that enables local, targeted delivery of large macromolecules across skin, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol RVNC, with Cowen & Co. and Piper Jaffray serving as lead underwriters. Shareholders include Essex Woodlands Health Ventures (36.2% pre-IPO stake), NovaQuest Capital (24.9%), Technology Partners (7.6%), Vivo Ventures (7%), Shepherd Ventures, Palo Alto Investors, Pac-Link Ventures and Essex Capital Corp. www.revance.com

OTHER DEALS

21st Century Fox (Nasdaq: FOXA) has agreed to sell its 47% stake in Star China TV to the channel’s majority owner, China Media Capital. No financial terms were disclosed. www.21cf.com

Fiat SpA has agreed to acquire the 41.46% stake in Chrysler that it does not already own, in a $4.35 billion deal.

Jonas Software, a unit of Constellation Software Inc. (TSX: CSU), has acquired Shortcuts Software Ltd., an Australia–based provider of business management solutions for the hair and beauty industry. No financial terms were disclosed. www.shortcutssoftware.com

Northern & Shell, a group owned by Richard Desmond, is considering a sale of British broadcast TV station Channel 5, according to the FT. Barclays is managing the process, which could garner around $1.2 billion.

PTC (Nasdaq: PTC) has acquired ThingWorx, an Exton, Penn.-based application development platform. The deal is valued at up to $130 million, including a $112 million up-front payment. ThingWorx backers included Safeguard Scientifics. www.thingworx.com

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com

About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in

EconomyAgriculture
More financially distressed farmers are expected to lose their property soon as loan repayments and incomes continue to falter
By Jason MaDecember 13, 2025
30 minutes ago
Middle EastMilitary
Trump pledges retaliation after 3 Americans are killed in Syria attack that the U.S. blames on the Islamic State group
By Samar Kassabali, Bassem Mroue, Seung Min Kim and The Associated PressDecember 13, 2025
2 hours ago
InvestingStock
There have been head fakes before, but this time may be different as the latest stock rotation out of AI is just getting started, analysts say
By Jason MaDecember 13, 2025
4 hours ago
Politicsdavid sacks
Can there be competency without conflict in Washington?
By Alyson ShontellDecember 13, 2025
4 hours ago
Investingspace
SpaceX sets $800 billion valuation, confirms 2026 IPO plans
By Loren Grush, Edward Ludlow and BloombergDecember 13, 2025
5 hours ago
PoliticsAffordable Care Act (ACA)
With just days to go before ACA subsidies expire, Congress is about to wrap up its work with no consensus solution in sight
By Kevin Freking, Lisa Mascaro and The Associated PressDecember 13, 2025
5 hours ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
24 hours ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple CEO Tim Cook out-earns the average American’s salary in just 7 hours—to put that into context, he could buy a new $439,000 home in just 2 days
By Emma BurleighDecember 12, 2025
1 day ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.